$BRFH Balance Sheet | Understand Stock

$BRFH

$0.60 +$0.02 (3.41%) Close

$BRFH Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current assets:
Cash
Restricted cash
Trade accounts receivable, net
Other receivables
Inventory, net
Prepaid expenses and other current assets
Total current assets

Property, plant and equipment, net of depreciation
Operating lease right-of-use assets, net
Intangible assets, net of amortization
Deposits
Other non-current assets
Total assets
Liabilities and Stockholders’ Equity
Current liabilities:
Line of credit
Accounts payable - trade
Accounts payable - construction in progress
Disputed co-manufacturer accounts payable (Note 5)
Accrued expenses
Advance payment
Accrued payroll and employee related expenses
Accrued vacation
Accrued interest
Lease liability
Loan payable - Paycheck Protection Program
Financing agreements - current
Debt
Notes payable
Total current liabilities

Accrued interest
Lease liability, net of current portion
Loan payable - Paycheck Protection Program
Other non-current liabilities
Financing agreements
Convertible notes
Total liabilities
Stockholders’ (deficit) equity:
Common stock, $0.000001 par value; 35,000,000 shares authorized; and 16,208,160 and 15,969,281 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Additional paid in capital
Accumulated deficit
Total stockholders’ (deficit) equity

Total liabilities and stockholders’ (deficit) equity

Comments